Evidence map›Paper›PMID 33882749›Full record

ArticleSLAS discovery : advancing life sciences R & D2021

In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors.

Brice A P Wilson, Donna Voeller, Emily A Smith, Antony Wamiru, Ekaterina I Goncharova, Gang Liu, Stanley Lipkowitz, Barry R O'Keefe

Open access · greenAbstract read
In one paragraph

Article in SLAS discovery : advancing life sciences R & D, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Brice A P WilsonMolecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0001-8988-1964
Donna VoellerWomen's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Emily A SmithMolecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Antony WamiruMolecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Ekaterina I GoncharovaMolecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Gang LiuDepartment of Pharmacology and Pharmaceutical Sciences, School of Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.
Stanley LipkowitzWomen's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Barry R O'KeefeMolecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Target (United States) · USLeidos (United States) · USNational Institutes of Health · USChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Cbl Proteins as Regulators of Tyrosine Kinase SignalingZIABC010977 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LIPKOWITZ, STANLEY · 2009 to 2025
$13.4M
Assay development and screening for molecular targets and discoveryZIABC011904 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WILSON, BRICE · 2019 to 2025
$12.8M
Cell-free assay technologies for the identification of active compoundsZIABC011471 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OKEEFE, BARRY · 2012 to 2025
$12.4M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC010977Intramural NIH HHS ZIA BC011904NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

The transfer of the small protein ubiquitin to a target protein is an intricately orchestrated process called ubiquitination that results in modulation of protein function or stability. Proper regulation of ubiquitination is essential, and dysregulation of this process is implicated in several human diseases. An example of a ubiquitination cascade that is a central signaling node in important disease-associated pathways is that of CBLB [a human homolog of a viral oncogene

Indexed as

In Vitro TechniquesAnimalsDrug DiscoveryEnzyme InhibitorsHigh-Throughput Screening AssaysHumansMethylationMiceSignal TransductionSmall Molecule LibrariesUbiquitinationUbiquitin-Protein LigasesEnzyme InhibitorsSmall Molecule LibrariesUbiquitin-Protein LigasesCBLE3high throughputinhibitorubiquitin ligase

Identifiers

PMID33882749
PMCPMC9907454
OpenAlexW3155228219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.